A novel trypsin Kazal-type inhibitor from Aedes aegypti with thrombin coagulant inhibitory activity
Biochemistry paper published in Biochimie (2010)
Abstract
Kazal-type inhibitors play several important roles in invertebrates, such as anticoagulant, vasodilator and antimicrobial activities. Putative Kazal-type inhibitors were described in several insect transcriptomes. In this paper we characterized for the first time a Kazal unique domain trypsin inhibitor from the Aedes aegypti mosquito. Previously, analyses of sialotranscriptome of A. aegypti showed the potential presence of a Kazal-type serine protease inhibitor, in female salivary glands, carcass and also in whole male, which we named AaTI (A. aegypti trypsin inhibitor). AaTI sequence showed amino acid sequence similarity with insect thrombin inhibitors, serine protease inhibitor from Litopenaeus vannamei hemocytes and tryptase inhibitor from leech Hirudo medicinalis (LDTI). In this work we expressed, purified and characterized the recombinant AaTI (rAaTI). Molecular weight of purified rAaTI was 7 kDa rAaTI presented dissociation constant (K(i)) of 0.15 and 3.8 nM toward trypsin and plasmin, respectively, and it weakly inhibited thrombin amidolytic activity. The rAaTI was also able to prolong prothrombin time, activated partial thromboplastin time and thrombin time. AaTI transcription was confirmed in A. aegypti female salivary gland and gut 3 h and 24 h after blood feeding, suggesting that this molecule can act as anticoagulant during the feeding and digestive processes. Its transcription in larvae and pupae suggested that AaTI may also play other functions during the mosquito's development.
Abstract sourced from PubMed (NCBI) for the cited record. See the original publication for the authoritative version.
Summary
Recombinant AaTI, a Kazal-type trypsin inhibitor first identified in the Aedes aegypti sialotranscriptome, shows sequence similarity to the leech Hirudo medicinalis tryptase inhibitor LDTI and prolongs prothrombin, activated partial thromboplastin and thrombin times.
Context
This study characterized AaTI, a novel Kazal-type trypsin inhibitor from the mosquito Aedes aegypti, which showed amino acid sequence similarity with insect thrombin inhibitors and the tryptase inhibitor LDTI from the leech Hirudo medicinalis. The recombinant AaTI (7 kDa) inhibited trypsin (Ki 0.15 nM) and plasmin (Ki 3.8 nM), weakly inhibited thrombin amidolytic activity, and prolonged prothrombin time, activated partial thromboplastin time, and thrombin time. The study identifies a structural and functional class of serine protease inhibitors (Kazal-type) that includes leech-derived molecules like LDTI, suggesting shared molecular strategies across hematophagous invertebrates for facilitating blood feeding through anticoagulation. This study concerns a mosquito protein, not leeches or leech-derived substances; the leech connection is limited to sequence homology, and no leech secretome components were isolated, tested, or characterized.
Citation
Reference (Vancouver style)
Watanabe RM, Soares TS, Morais-Zani K, Tanaka-Azevedo AM, Maciel C, Capurro ML, et al. A novel trypsin Kazal-type inhibitor from Aedes aegypti with thrombin coagulant inhibitory activity. Biochimie. 2010;92(8):933-939. doi:10.1016/j.biochi.2010.03.024. PMID: 20363282
Bibliographic details (authors, volume, pages, DOI) are taken from the PubMed record.
Added to ASH library: May 27, 2026 · Site last updated: November 1, 2026